Todd W. Miller
机构:Dartmouth College, Medical College of Wisconsin · ORCID:0000-0001-8912-2909
发表论文 484 篇 · 总被引 5677 次 · h-index 37
代表论文
- Metabolic Response to CDK4 /6 Inhibition in ER + Breast Cancer Creates a Therapeutic Vulnerability in Drug‐Tolerant Persister Cells (2026 · The FASEB Journal · 被引 1)
- Pharmacological chromatin remodeling enhances response to estrogen therapy in ER + breast cancer (2026 · Molecular Oncology)
- Epithelial-mesenchymal transition is associated with altered immune composition and cytotoxic function in triple-negative breast cancer (2026 · Breast Cancer Research)
- Suppl. Figure 1 from Oxidative Phosphorylation Is a Metabolic Vulnerability of Endocrine Therapy–Tolerant Persister Cells in ER+ Breast Cancer (2026)
- Suppl. Figure 2 from Oxidative Phosphorylation Is a Metabolic Vulnerability of Endocrine Therapy–Tolerant Persister Cells in ER+ Breast Cancer (2026)
- Supplementary Table 9 from Oxidative Phosphorylation Is a Metabolic Vulnerability of Endocrine Therapy–Tolerant Persister Cells in ER+ Breast Cancer (2026)